Stay updated on TATE-PD1 Combo in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TATE-PD1 Combo in Liver Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The NIH banner announcing a website transition and the use of “Super Intelligence” terminology has been removed.
    Difference
    1%
    Check dated 2026-11-08T06:34:29.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T04:36:03.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    A notice was added announcing NIH website changes and describing the agency’s transition from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T06:43:40.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T06:30:02.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T08:38:53.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the previous study details. This indicates the NCT03259867 record is currently inaccessible from the site.
    Difference
    19%
    Check dated 2026-09-20T03:57:40.000Z thumbnail image

Stay in the know with updates to TATE-PD1 Combo in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.